Duke Energy Corp vs Davita Inc — how do they compare? Duke Energy Corp trades at $116.65 (market cap $91.10B), while Davita Inc trades at $179.05 (market cap $11.29B). The key difference: Duke Energy Corp is far larger — about 8.1× Davita Inc's market cap, and Duke Energy Corp pays a 3.71% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 74 Days and Davita Inc for 114 Days on average.
| DUK | DVA | |
|---|---|---|
Market Cap | $91.10B | $11.29B |
Volume | 4,199,050 | 582,204 |
Sector | Utilities | Health |
52-Week High | $133.46 | $240.96 |
52-Week Low | $113.23 | $103.87 |
Typical Hold Time | 74 Days | 114 Days |
Enterprise Value | $183.61B | $24.01B |
Dividend Yield | 3.71% | — |
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $116.65, up 1.0% today, with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with a 15.78% net income margin and a dividend yield supported by recent $1.09 payouts. Revenue growth is steady, reaching $32.24B in 2025, while analyst consensus targets $134.44, implying upside potential.
The outlook is positive due to earnings momentum and data center demand, but risks include rising Treasury yields pressuring utility stocks and high debt levels. Investors should weigh the reliable dividend against interest rate sensitivity and capital expenditure needs for growth initiatives.
DaVita (DVA) trades at $179.25, up 1.4% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows mixed technical signals with bearish moving averages but neutral oscillators, trading near resistance at $179. Fundamentally, revenue growth continues with 2025 revenue reaching $13.64B, though net margins compressed to 5.47% from 7.3% in 2024. Recent partnership expansion with Humana for value-based kidney care represents significant growth opportunity.
Outlook remains positive with analyst consensus target of $235.67 implying 31% upside, though elevated debt levels and regulatory risks require monitoring. The company benefits from demographic tailwinds in kidney care services and strong institutional support, including Berkshire Hathaway's 45% stake, providing stability amid market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →